{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:58:23Z","timestamp":1761551903057,"version":"build-2065373602"},"reference-count":20,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,20]]},"DOI":"10.5334\/gh.1153","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T06:39:16Z","timestamp":1663655956000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Patients\u2019 Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs"],"prefix":"10.5334","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-4389","authenticated-orcid":false,"given":"Pamela","family":"Pi\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-7221","authenticated-orcid":false,"given":"Amparo","family":"Taveras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5412-4207","authenticated-orcid":false,"given":"Amir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-8190","authenticated-orcid":false,"given":"Justin","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-8770","authenticated-orcid":false,"given":"Victor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1917-5623","authenticated-orcid":false,"given":"Luis","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-0940","authenticated-orcid":false,"given":"Santiago","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3975-0998","authenticated-orcid":false,"given":"Ann","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5539-6861","authenticated-orcid":false,"given":"Sorin","family":"Danciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-5225","authenticated-orcid":false,"given":"Cesar J.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","reference":[{"issue":"4","key":"key20220920063901_B1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"key20220920063901_B2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"key20220920063901_B3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","year":"2019","journal-title":"Int J Cancer"},{"issue":"2","key":"key20220920063901_B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012: Global Cancer Statistics, 2012","volume":"65","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20220920063901_B5","first-page":"12","article-title":"Prevalencia de hipertensi\u00f3n arterial y factores de riesgo cardiovasculares en Rep\u00fablica Dominicana (ENPREFAR- HAS 17)","year":"2017","journal-title":"Archivos Dominicanos de Cardiolog\u00eda"},{"issue":"10","key":"key20220920063901_B6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","year":"2014","journal-title":"Eur Heart J \u2013 Cardiovasc Imaging"},{"key":"key20220920063901_B7","first-page":"5","article-title":"Consenso de diagn\u00f3stico, prevenci\u00f3n y tratamiento de la cardiotoxicidad por tratamiento m\u00e9dico del c\u00e1ncer","volume":"81","year":"2013","journal-title":"Rev Argen Cardiol"},{"issue":"3","key":"key20220920063901_B8","first-page":"107","article-title":"Cardiotoxicidad inducida por Trastuzumab en pacientes uruguayas portadoras de c\u00e1ncer de mama HER positivo","volume":"37","year":"2015","journal-title":"Arch Med Interna"},{"key":"key20220920063901_B9","first-page":"1","article-title":"Evaluaci\u00f3n card\u00edaca de pacientes con c\u00e1ncer de mama tratadas con antraciclinas","volume":"23","year":"2017","journal-title":"Revi Cubana Cardiol Cir CV"},{"key":"key20220920063901_B10","first-page":"105","article-title":"Cardiotoxicity alerts during treatment with trastuzumab in breast cancer at four-year Follow-up","volume":"87","year":"2019","journal-title":"Rev Argent Cardiol"},{"key":"#cr-split#-key20220920063901_B11.1","doi-asserted-by":"crossref","unstructured":"Makavos G, Ikonomidis I, Palios J, et al. Cardiac imaging in cardiotoxicity: a focus on clinical practice. Heart Fail Rev [Internet]. 2020 [cited 2020 May 4]","DOI":"10.1007\/s10741-020-09952-w"},{"key":"#cr-split#-key20220920063901_B11.2","unstructured":"10. http:\/\/link.springer.com\/10.1007\/s10741-020-09952-w (assessed 4 May 2020)."},{"issue":"10","key":"key20220920063901_B12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"22","key":"key20220920063901_B13","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","article-title":"Randomized trial of Lisinopril versus Carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"key20220920063901_B14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"issue":"20","key":"key20220920063901_B15","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for prevention of chemotherapy-related cardiotoxicity: The CECCY Trial","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220920063901_B16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-019-0298-6","article-title":"Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials","volume":"20","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"key20220920063901_B17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3747\/co.20.1470","article-title":"Predicting the risk of cardiovascular comorbidities in adult cancer survivors","volume":"20","year":"2013","journal-title":"Curr Oncol"},{"issue":"23","key":"key20220920063901_B18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality","volume":"101","year":"2015","journal-title":"Heart"},{"key":"key20220920063901_B19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of Anthracyclines","volume":"7","year":"2020","journal-title":"Front Cardiovasc Med"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-gh-files\/journals\/1\/articles\/1153\/submission\/proof\/1153-1-5241-1-10-20220920.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:51:25Z","timestamp":1761551485000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1153\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,9,20]]}},"alternative-id":["10.5334\/gh.1153"],"URL":"https:\/\/doi.org\/10.5334\/gh.1153","relation":{},"ISSN":["2211-8179"],"issn-type":[{"type":"electronic","value":"2211-8179"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"67"}}